HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An aggressive extramedullary cutaneous plasmacytoma associated with extreme alterations in the innate immune system.

AbstractBACKGROUND:
The role of natural killer (NK) cells in plasma cell diseases has not yet been fully characterized.
CASE REPORT:
We present the case of a 47-year-old man with an extremely aggressive extramedullary plasmacytoma of the lung with associated cutaneous lesions, whose disease was accompanied by a significantly decreased number of NK cells (CD56+, CD16+, CD3-) in the peripheral blood, very low NK cell activity levels, and a decreased interleukin-2 production from cultured cells in vitro. Histology and immunohistochemistry of the lung and cutaneous lesions identified that the tumor was composed of clonal plasma cells which were CD38+++, CD138+++, lambda chain+, kappa chain-, and cytokeratin-. Bone marrow histology and cytology were initially normal. The disease progressed rapidly despite local radiotherapy and systemic chemotherapy, and the patient died shortly after diagnosis.
CONCLUSIONS:
Cutaneous involvement in extramedullary plasmacytoma represents a clinically aggressive variant of plasma cell tumor, which runs a rapid course and has associated devastating effects on the patient's innate immune system.
AuthorsVladimir Jurisic, Natasa Colovic, Gordana Konjevic, Ivana Minic, Milica Colovic
JournalOnkologie (Onkologie) Vol. 33 Issue 3 Pg. 113-5 ( 2010) ISSN: 1423-0240 [Electronic] Switzerland
PMID20215803 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 S. Karger AG, Basel.
Topics
  • Humans
  • Immune System Diseases (complications, pathology)
  • Killer Cells, Natural (pathology)
  • Male
  • Middle Aged
  • Plasmacytoma (complications, pathology)
  • Skin Neoplasms (complications, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: